Innate and adaptive immunity in acute myocarditis

M Golino, D Harding, MG Del Buono, S Fanti… - International Journal of …, 2024 - Elsevier
Acute myocarditis is an acute inflammatory cardiomyopathy associated with cardiac damage
triggered by a virus or a pathological immune activation. It may present with a wide range of …

Understanding long COVID myocarditis: A comprehensive review

A Srivastava, SN Sundararaj, J Bhatia, DS Arya - Cytokine, 2024 - Elsevier
Infectious diseases are a cause of major concern in this twenty-first century. There have
been reports of various outbreaks like severe acute respiratory syndrome (SARS) in 2003 …

[HTML][HTML] Mechanical Circulatory Support Systems in Fulminant Myocarditis: Recent Advances and Outlook

M Lenz, KA Krychtiuk, R Zilberszac, G Heinz… - Journal of Clinical …, 2024 - mdpi.com
Background: Fulminant myocarditis (FM) constitutes a severe and life-threatening form of
acute cardiac injury associated with cardiogenic shock. The condition is characterised by …

Effectiveness and safety of IL1 inhibition with anakinra in chronic refractory idiopathic myocarditis

D Malandrino, F Bello, G Lopalco, L Cantarini… - Internal and Emergency …, 2024 - Springer
Aim The aim of this study was to evaluate the effectiveness and safety of the anti-IL-1
receptor anakinra in patients with chronic active myocarditis refractory to standard therapy …

Clinical course and peculiarities of Parechovirus and Enterovirus central nervous system infections in newborns: a single-center experience

G Brisca, T Bellini, M Pasquinucci, M Mariani… - European Journal of …, 2024 - Springer
Abstract Parechovirus (HpEV) and Enterovirus (EV) infections in children mostly have a mild
course but are particularly fearsome in newborns in whom they may cause aseptic …

[HTML][HTML] Multisystem inflammatory syndrome in children during the COVID-19 waves: data from the Juvenile Inflammatory Rheumatism cohort

R Kechiche, C Borocco, F Bajolle, A Belot… - Frontiers in …, 2023 - frontiersin.org
Introduction Multisystem inflammatory syndrome in children (MIS-C) is a new condition that
first appeared in children and adolescents during the COVID-19 pandemic. We aimed to …

[HTML][HTML] Subcutaneous anakinra in the management of refractory MIS-C in France

P Dusser, A Belot, F Bajolle… - Frontiers in …, 2024 - frontiersin.org
Introduction Multisystemic inflammatory syndrome in children (MIS-C) is a therapeutic
emergency and can lead to myocardial dysfunction (17%–75%) and heart failure (52 …

Analysis of Cytokine Profiles in Pediatric Myocarditis Multicenter Study

Y Nomura, T Suzuki, K Kunida, H Uchida, R Ito… - Pediatric …, 2024 - Springer
Acute myocarditis (AM) is an inflammatory disease of the heart muscle that can progress to
fulminant myocarditis (FM), a severe and life-threatening condition. The cytokine profile of …

Current treatment and immunomodulation strategies in Acute Myocarditis

E Ferone, A Segev, E Tempo, P Gentile… - Journal of …, 2022 - journals.lww.com
Myocarditis is an inflammatory disease of the myocardium characterized by a great
heterogeneity of presentation and evolution. Treatment of myocarditis is often supportive …

[PDF][PDF] Multisystem inflammatory syndrome in children during the COVID-19 waves: data from the Juvenile Inflammatory Rheumatism cohort

G Simonini, C Galeotti, R Kechiche, C Borocco… - 2023 - scienceopen.com
Results: We identified 136 patients with MIS-C. The median age decreased but not
significantly during the waves, from 9.9 years to 7.3 years (p= 0.105). Boys represented …